Global Oral Insulin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Oral Insulin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.
Oral Insulin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Insulin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Female and Male are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Insulin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Insulin key manufacturers include Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics, Diabetology, Generex Biotechnology, Coromed and Nektar Therapeutics, etc. Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics are top 3 players and held % sales share in total in 2022.
Oral Insulin can be divided into Type 1 Diabetes and Type 2 Diabetes, etc. Type 1 Diabetes is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Insulin is widely used in various fields, such as Female and Male, etc. Female provides greatest supports to the Oral Insulin industry development. In 2022, global % sales of Oral Insulin went into Female filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Insulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Novo Nordisk
Oramed Pharmaceuticals
vTv Therapeutics
Diabetology
Generex Biotechnology
Coromed
Nektar Therapeutics
Segment by Type
Type 1 Diabetes
Type 2 Diabetes
Female
Male
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Oral Insulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Insulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Insulin industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Oral Insulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Insulin introduction, etc. Oral Insulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Insulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Oral Insulin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Insulin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Female and Male are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Oral Insulin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Oral Insulin key manufacturers include Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics, Diabetology, Generex Biotechnology, Coromed and Nektar Therapeutics, etc. Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics are top 3 players and held % sales share in total in 2022.
Oral Insulin can be divided into Type 1 Diabetes and Type 2 Diabetes, etc. Type 1 Diabetes is the mainstream product in the market, accounting for % sales share globally in 2022.
Oral Insulin is widely used in various fields, such as Female and Male, etc. Female provides greatest supports to the Oral Insulin industry development. In 2022, global % sales of Oral Insulin went into Female filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Insulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novo Nordisk
Oramed Pharmaceuticals
vTv Therapeutics
Diabetology
Generex Biotechnology
Coromed
Nektar Therapeutics
Segment by Type
Type 1 Diabetes
Type 2 Diabetes
Segment by Application
Female
Male
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Oral Insulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Insulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Insulin industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Oral Insulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Insulin introduction, etc. Oral Insulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Oral Insulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.